NIRS Monitoring in the NICU and AKI
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age24-30
SponsorNYU Langone Health
About this trial
The primary objective of this study is to describe the pattern of renal tissue oxygen saturation (SrSO2) using near-infrared spectroscopy (NIRS) in premature infants \<30 weeks gestational age. The secondary objective of this study is to evaluate prenatal and postnatal risk factors for acute kidney injury (AKI) in premature infants \<30 weeks gestational age. The investigators will also compare various rates of complications including death, length-of-stay, and prolonged duration of mechanical ventilation, among others.
Eligibility criteria
Qualifiers
Any neonate less than 30 weeks in gestational age
Willingness and capacity of both adult parents/guardians to sign consent
Disqualifiers
An infant with known congenital anomalies of the kidney (i.e., grade 4 or 5 vesicoureteral reflux (VUR), posterior urethral valves, moderate or severe hydronephrosis, autosomal recessive polycystic kidney disease (ARPKD), bilateral renal agenesis or dysplasia)
Age >30 weeks gestational age
Age <24 weeks and <500 grams (will be excluded due to sensitivity of skin in this vulnerable population).
Clinician's decision that NIRS is not suitable due to the patient's clinical condition
Trial design
Treatments tested in this trial
- NIRS Monitoring
Treatment groups
100 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov